Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Axial Spondyloarthritis (ABILITY-1)
NCT00939003Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jul 2009
- Primary completion
- Feb 2011
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 3 trial of adalimumab in non-radiographic axial spondyloarthritis (nr-axSpA), sponsored by AbbVie Inc.. Started Jul 2009; status: completed.
02
Drugs
03
Conditions
non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on NCT00939003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939003.